Advertisement

Topics

Imagin Molecular Company Profile

10:22 EDT 21st June 2018 | BioPortfolio

Imagin Molecular Corporation is dedicated to business opportunities in the nuclear medicine field with its primary focus in positron emission tomography (PET). PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders. Imagin Molecular is a publicly traded Delaware corporation on the OTCBB under the symbol IMGM. Imagin Molecular is a holding company actively engaged in businesses such as nuclear medicine device manufacturing, coronary artery disease reversal and prevention molecular imaging centers with hospital joint ventures. Currently Imagin Molecular is the parent of three wholly owned operating subsidiaries. 1. Imagin Nuclear Partners Imagin Nuclear Partners is a full-service joint venture molecular imaging partner that will own, operate and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment. Imagin Nuclear Partners specializes in using evidence based bioinformatics specifically positioned in the market to provide the maximal cost-effective benefit to the Company’s joint venture partner and community. Imagin Nuclear Partners currently operates a PET center within Beth Israel Hospital in New York. Imagin Nuclear Partners uses the Positron HZL-R cardiac specific imaging camera from Positron Corporation. Imagin Nuclear Partners was formed to provide PET and related technical and educational services to diagnose and treat patients with coronary artery disease and who are at risk of developing coronary heart disease. Corporation is headquartered in Niagara Falls, New York. 2. Positron Acquisition Corporation Positron Acquisition Corporation was formed for the sole purpose of holding securities in Positron Corporation (www.positron.com) that were acquired in conjunction with a share exchange with Imagin Diagnostic Centres of Canada. Positron Acquisition Corporation currently holds 70,400,000 common shares of Positron Corporation. Imagin Molecular Corporation acquired this position to add value to its portfolio of PET businesses. Positron's leading cardiac PET software and device provides the complete solution for Imagin Molecular Corporation’s CAD reversal and prevention centers plan. Positron Corporation’s superior technology combined with the most economic camera and expertise is the total solution for Imagin Molecular Corporation and any PET facility. 3. Cipher Multimedia, Inc. Cipher Multimedia is a new Media Marketing and Distribution Solution Company that provides a Distribution Solution for publishers of digital content. Cipher Multimedia will develop marketing campaigns that will assist Imagin, Positron Corporation and other companies market their products and will continue to provide publishers a distribution solution for digital content. Imagin Molecular Corporation is in the process of spinning this company off through a stock dividend to its shareholders.

Location

104 W. Chestnut St. #315
Hinsdale
IL
60521
United States of America

Contact

Phone: 630/371-5583
Fax: 630/371-5584
Email: contact@imaginmolecularcorp.com


News Articles [478 Associated News Articles listed on BioPortfolio]

Imagin Medical Research Study Begins

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 22, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company"), as a follow-up to...

American Urological Association (AUA) Honors Imagin Medical Scientific Advisor

VANCOUVER, BC and BOSTON, MA--(Marketwired - February 13, 2018) - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company"), announced today that the lead investigato...

Imagin Medical Builds Momentum for 2018

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 09, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company") announced that cri...

Global Molecular Diagnostic Testing Market 2016-2021 - Expected High Growth in Molecular ...

Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. Read more...

Imagin Medical Recruits Senior Healthcare Industry CFO

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 15, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company") announced today th...

The Molecular Autopsy: Not Ready Yet for Prime Time

Although I have always been a strong advocate for sophisticated molecular and genomic testing, I tend to get a severe case of indigestion when I see references to the molecular autopsy (see: Can Inter...

Molecular Health introduces MH Mendel to help geneticists in diagnosing hereditary diseases

Molecular Health, a leading biomedical company that is transforming molecular data into clinically actionable information for efficient and safer cancer treatment options based on its proprietary Data...

Molecular POC Market to Reach USD 510 Million by 2023

The molecular point-of-care market (POC), consisting of systems with molecular capability used in decentralized test environments, was worth an estimated...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Salsalate [Libertas Pharma, Inc.]

Salsalate Tablets, USP 500 and 750 mgRx Only

PubMed Articles [580 Associated PubMed Articles listed on BioPortfolio]

How Secondary and Tertiary Amide Moieties are Molecular Stations for Dibenzo-24-crown-8 in 2Rotaxane Molecular Shuttles?

Interlocked molecular machines like [2]rotaxanes are intriguing aesthetic molecules. The control of the localization of the macrocycle, which surrounds a molecular axle, along the thread leads to tran...

Molecular imaging and molecular diagnostics: two sides of the same coin?

Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.

The aim of this article is to discuss how allergen-specific immunotherapy (AIT) can be improved through molecular approaches. We provide a summary of next-generation molecular AIT approaches and of th...

Molecular Illustration in Research and Education: Past, Present, and Future.

2D illustration is used extensively to study and disseminate the results of structural molecular biology. Molecular graphics methods have been and continue to be developed to address the growing needs...

Negative thermal expansion in molecular materials.

Negative thermal expansion (NTE), whereby lattices contract upon heating, is of considerable interest for its wide applications in many fields. Molecular materials have been widely investigated as cat...

Clinical Trials [1239 Associated Clinical Trials listed on BioPortfolio]

Multimodal Imaging in Central Serous Chorioretinopathy

This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive opti...

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.

In Vivo EGFR Molecular Classification

The investigators developed 18F-MPG as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-activating mutational status.

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the k...

Validation of a Molecular Prognostic Test for Eye Melanoma

Up to half of patients with ocular melanoma (also called iris, choroidal or uveal melanoma) develop metastasis. We have found that certain molecular features of the eye tumor can be detect...

Companies [842 Associated Companies listed on BioPortfolio]

Imagin Molecular Corporation

Imagin Molecular Corporation (IMGM) is a company dedicated to socially responsible issues. IMGM main areas of interest are focused on medical and environmental. IMGM through its s...

Imagin Molecular

Imagin Molecular Corporation is dedicated to business opportunities in the nuclear medicine field with its primary focus in positron emission tomography (PET). PET is an advanced medical diagnostic im...

ABT Molecular Imaging

ABT Molecular Imaging is a medical imaging company marketing its Generator, a production platform which produces unit doses of molecular imaging drugs for positron emission tomogr...

HTG Molecular Diagnostics

HTG Molecular Diagnostics is a leading provider of molecular-based solutions for gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic appli...

Natural Molecular Testing Corp.

Natural Molecular Testing Corporation (NMTC) is a privately-owned, high-complexity molecular testing facility. NMTC provides genetic testing services and resources for our clinica...

More Information about "Imagin Molecular" on BioPortfolio

We have published hundreds of Imagin Molecular news stories on BioPortfolio along with dozens of Imagin Molecular Clinical Trials and PubMed Articles about Imagin Molecular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Imagin Molecular Companies in our database. You can also find out about relevant Imagin Molecular Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record